Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti–PD-1 and Anti-CD137 Monoclonal Antibodies-Reference-Cited by-同舟云学术

Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti–PD-1 and Anti-CD137 Monoclonal Antibodies

Published:2016-04 Issue:4 Volume:11 Page:524-536
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Azpilikueta Arantza,Agorreta Jackeline,Labiano Sara,Pérez-Gracia José Luis,Sánchez-Paulete Alfonso R.,Aznar M. Angela,Ajona Daniel,Gil-Bazo Ignacio,Larrayoz Marta,Teijeira Alvaro,Rodriguez-Ruiz María E.,Pio Ruben,Montuenga Luis M.,Melero Ignacio

Funder

MICINN

FIS

Redes temáticas de investigación cooperativa

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference54 articles.

1. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

2. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med,2015

3. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients;Herbst;Nature,2014

4. Immune modulation in cancer with antibodies;Page;Annu Rev Med,2014

5. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential;Sharma;Cell,2015

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetically powered cancer cell microrobots for surgery-free generation of targeted tumor mouse models;Cell Reports Physical Science;2024-09

2. CD137 (4-1BB) and T-Lymphocyte Exhaustion;Clinical Cancer Research;2024-07-19

3. Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism;OncoImmunology;2024-07-09

4. ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1;Cancer Immunology, Immunotherapy;2023-10-05

5. Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions;Frontiers in Oncology;2023-09-25